Raquel Bouça-Machado1,2, Gonçalo S Duarte1,3, Maria Patriarca2, Ana Castro Caldas2, Joana Alarcão4, Ricardo M Fernandes1,3,5, Tiago A Mestre6, Ricardo Matias7,8, Joaquim J Ferreira1,2. 1. Instituto de Medicina Molecular, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal. 2. CNS-Campus Neurológico Sénior Torres Vedras Portugal. 3. Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal. 4. Center for Evidence-Based Medicine, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal. 5. Department of Pediatrics Santa Maria Hospital Lisbon Portugal. 6. Parkinson's disease and Movement Disorders Center, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute University of Ottawa Brain and Research Institute Ottawa Ontario Canada. 7. Champalimaud Research and Clinical Centre Champalimaud Centre for the Unknown Lisbon Portugal. 8. Human Movement Analysis Lab Escola Superior Saúde-Instituto Politécnico de Setúbal Setúbal Portugal.
Abstract
BACKGROUND: Functional mobility (FM) is a person's ability to move to accomplish activities of daily living; it bridges the concepts of mobility and functional ability. There is frequently a loss of FM in Parkinson's disease (PD). Several instruments have been used to assess this concept in PD; however, there is no consensus on which are the most appropriate. OBJECTIVE: We aimed to identify and critically appraise which measurement instruments have been used to assess FM. METHODS: A systematic review was conducted using the databases CENTRAL, MEDLINE, Embase, and PEDro from their inception to January 2019 to identify all observational and experimental studies conducted in PD or atypical parkinsonism that included an FM assessment. Two reviewers independently screened citations, extracted data, and assessed clinimetric properties. RESULTS: We included 95 studies that assessed FM in PD. Fifty-five (57.9%) studies mentioned FM in the article, and 39 (41.1%) specified the measurement tools used to evaluate FM. FM was the primary outcome in 12 (12.6%) studies. The Timed Up and Go test was the most frequently used measurement tool. Only one study presented a definition of FM. Several overlapping terms were used, the most common being mobility. CONCLUSION: Several studies reported the use of FM measurement tools in PD, though with frequent misconceptions, an inadequate context of use, or suboptimal assessment. We propose the establishment of the concept of FM applied to PD, followed by the adequate clinimetric validation of existing measurement tools to provide a comprehensive and reliable evaluation of FM in PD.
BACKGROUND: Functional mobility (FM) is a person's ability to move to accomplish activities of daily living; it bridges the concepts of mobility and functional ability. There is frequently a loss of FM in Parkinson's disease (PD). Several instruments have been used to assess this concept in PD; however, there is no consensus on which are the most appropriate. OBJECTIVE: We aimed to identify and critically appraise which measurement instruments have been used to assess FM. METHODS: A systematic review was conducted using the databases CENTRAL, MEDLINE, Embase, and PEDro from their inception to January 2019 to identify all observational and experimental studies conducted in PD or atypical parkinsonism that included an FM assessment. Two reviewers independently screened citations, extracted data, and assessed clinimetric properties. RESULTS: We included 95 studies that assessed FM in PD. Fifty-five (57.9%) studies mentioned FM in the article, and 39 (41.1%) specified the measurement tools used to evaluate FM. FM was the primary outcome in 12 (12.6%) studies. The Timed Up and Go test was the most frequently used measurement tool. Only one study presented a definition of FM. Several overlapping terms were used, the most common being mobility. CONCLUSION: Several studies reported the use of FM measurement tools in PD, though with frequent misconceptions, an inadequate context of use, or suboptimal assessment. We propose the establishment of the concept of FM applied to PD, followed by the adequate clinimetric validation of existing measurement tools to provide a comprehensive and reliable evaluation of FM in PD.
Authors: Anke H Snijders; Charlotte A Haaxma; Yolien J Hagen; Marten Munneke; Bastiaan R Bloem Journal: Parkinsonism Relat Disord Date: 2011-10-02 Impact factor: 4.891
Authors: Rita Pavasini; Jack Guralnik; Justin C Brown; Mauro di Bari; Matteo Cesari; Francesco Landi; Bert Vaes; Delphine Legrand; Joe Verghese; Cuiling Wang; Sari Stenholm; Luigi Ferrucci; Jennifer C Lai; Anna Arnau Bartes; Joan Espaulella; Montserrat Ferrer; Jae-Young Lim; Kristine E Ensrud; Peggy Cawthon; Anna Turusheva; Elena Frolova; Yves Rolland; Valerie Lauwers; Andrea Corsonello; Gregory D Kirk; Roberto Ferrari; Stefano Volpato; Gianluca Campo Journal: BMC Med Date: 2016-12-22 Impact factor: 8.775
Authors: Lucía Ortega-Pérez de Villar; Francisco José Martínez-Olmos; Anna Junqué-Jiménez; Juan José Amer-Cuenca; Javier Martínez-Gramage; Tom Mercer; Eva Segura-Ortí Journal: PLoS One Date: 2018-08-22 Impact factor: 3.240